Gene therapy of adenovirus mediated CD::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 643-650

  Wang, Zehua ^a   Cai, Liqiong ^a   Wang, Hongbo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adenovirus; CD::upp gene; Gene therapy; GSTP1

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; CYTOSINE DEAMINASE; FLUCYTOSINE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG; URACIL PHOSPHORIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CANCER CELL DESTRUCTION; CANCER RESISTANCE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE THERAPY; SURVIVAL RATE; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 13844281579     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.09.066     Document Type: Article

References (19)

1. National Institutes of Health Consensus Development conference statement Ovarian cancer: screening, treatment, and follow-up Gynecol. Oncol. 55 1994 4 14
2. R.F. Ozols, and R.C. Young Ovarian cancer: where to next Semin. Oncol. 18 3 1991 307 310
3. P.A. Vasey Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies Br. J. Cancer 89 Suppl 3 2003 523 528
4. I.B. Roninson, H.T. Abelson, D.E. Housman, N. Howell, and A. Varshavsky Cytometric study of intracellular P-gp expression and reversal of drug resistance Cytometry 32 1998 86 94
5. B. Mannervik, P. Alin, C. Guthenberg, H. Jensson, M.K. Tahir, and M. Warholm Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties Proc. Natl. Acad. Sci. U. S. A. 82 1985 7202 7206
6. M. Schultz, S. Dutta, and K.D. Tew Inhibitors of glutathione S-transferases as therapeutic targets Adv. Drug Deliv. Rev. 26 1997 91 104
7. K.D. Tew Glutathione-associated enzymes in anticancer drug resistance Cancer Res. 54 1994 4313 4320
8. R.P. Perez, T.C. Hamilton, and R.F. Ozols Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems Pharmacol. Ther. 48 1990 19 27
9. W. Huang, L. Li, and D. Tang Establishing of a new cisplatin-resistant cell line and studying its mechanism characterization of drug-resistance China Oncol. 8 1998 187 189
10. G.A. Chung-Faye, M.J. Chen, N.K. Green, A. Burton, D. Anderson, and V. Mautner In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyl transferase Gene Ther. 8 20 2001 1547 1554
11. P. Borde-Chiche, M. Diedericha, F. Morceau, A. Puga, M. Wellman, and M. Dicato Regulation of transcription of the glutathione s-transferase P1 gene by methylation of the minimal promoter in human leukemia cells Biochem. Pharmacol. 61 2001 605 612
12. T.C. He, S. Zhou, L.T. Da Costa, J. Yu, and K.W. Kinzler A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. U. S. A. 95 1998 2509 2514
13. D. Vandier, V. Calvez, L. Massade, A. Gouyette, L. Mickley, and T. Fojo Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategy J. Natl. Cancer Inst. 19 8 2000 642 647
14. S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, R.A. Morgan, and R. Moen Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction N. Engl. J. Med. 323 1990 570 578
15. A. Ido, H. Uto, A. Moriuchi, K. Nagata, Y. Onaga, and M. Onaga Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter Cancer Res. 61 7 2001 3016 3021
16. M.L. O'Brien, and K.D. Tew Glutathione and related enxymes in multidrug resistance Eur. J. Cancer 32 1996 967 978
17. E.S. Hwang, J. Kim, J.S. Kim, C. Kao, S.C. Ko, and L. Chung The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell line in vitro and in vivo Int. J. Gynecol. Cancer 8 1 1998 27 36
18. Y. Tsuruta, M. Mandai, I. Konishi, H. Kuroda, T. Kusakari, and Y. Yura Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines Eur. J. Cancer 37 4 2001(Mar) 531 541
19. J.K. Wolf, D.C. Bodurka, J.B. Gano, M. Deavers, L. Ramondetta, and P.T. Ramirez A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer Gynecol. Oncol. 94 2 2004 (Aug) 442 448